Rheopherese® bei altersbedingter Makuladegeneration (Q57338306)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Rheopherese® bei altersbedingter Makuladegeneration	No description defined

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Rheopherese® bei altersbedingter Makuladegeneration (English)

0 references

Gerald Gartlehner

object named as

G. Gartlehner

4

0 references

author name string

C. Wild

1

0 references

S. Mathis

2

0 references

B. Guba

3

0 references

publication date

21 May 2008

0 references

0 references

106

0 references

2

0 references

127-132

0 references

Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FS00347-008-1768-1

21 January 2018

Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis for dry AMD: controversy requiring mutual respect

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheopheresis for macular degeneration: the data is not there yet to justify it

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nonexudative (dry) age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current and future treatment options for nonexudative and exudative age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of macular function by membrane differential filtration in diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Determining visual acuity using European normal values: scientific principles and possibilities for automatic measurement]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes and prevalence of visual impairment among adults in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of membrane differential filtration on the colloid osmotic pressure in patients with age-related macular degeneration: significance to visual function?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abdominal pain, hypertension, and thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00347-008-1768-1

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57338306&oldid=2213413137"